Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)
Forecasted Federal grant Posted
- Opportunity number
- RFA-OH-27-048
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Applications expected due
- Award size
- $750,000 to $1,100,000
Opportunity facts
- Expected posting
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Higher Education Inst. (Public)
- City/Township Governments
- Tribal Governments (Federally Recognized)
- Other
- County Governments
- For Profit Organizations
- Unrestricted
- Independent School Districts
- Small Businesses
- Tribal Organizations (Not Federally Recognized)
- Non-501(c)(3) Nonprofits
- State Governments
- 501(c)(3) Nonprofits
- Special District Governments
- Public or Indian Housing Auth.
- Higher Education Inst. (Private)
- Points of contact
-
- Bridgette Garrett bgarrett@cdc.gov (770) 488-5715
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention is forecasting a cooperative agreement (U24) to continue and expand the National Mesothelioma Virtual Bank for Translational Research, posted July 22, 2026. The binding constraint is that applicants must have an established registry and tissue bank with the capability of functioning as a national virtual registry and tissue bank for mesothelioma, in which participating institutions make their independent stores of mesothelioma tissue available for public access and use through a centralized Internet-based database. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible, and foreign components, as defined in the HHS Grants Policy Statement, are not allowed.
The listed applicant types include public and private institutions of higher education, city, county, state, and tribal governments, independent school districts, public housing authorities, 501(c)(3) and non-501(c)(3) nonprofits, for-profit organizations, and small businesses, subject to the registry and tissue bank requirement.
The work adds biospecimens to the bank, including fresh frozen tumor and control tissues, paraffin-embedded tissues, blood, DNA, RNA, and protein samples from mesothelioma patients. Each specimen set pairs with demographic data (age, sex, race, occupational history) and clinical data (stage, treatment, survival information). The bank was established in 2006 and supports genomic, transcriptomic, and proteomic data use by investigators. The stated objectives are to help identify early signs of disease, support development of biomarkers showing disease stage and prognosis, and help develop new or improved treatment options.
The opportunity is assigned to Assistance Listing 93.262, Occupational Safety and Health Program.
Forecast synopsis
The National Mesothelioma Virtual Bank (NMVB) was established in 2006 to serve as a resource for malignant mesothelioma research. This funding opportunity will advance biomedical research for malignant mesothelioma by adding more biospecimens together with demographic data and clinical data.
Examples of biospecimens include fresh frozen tumor and control tissues, paraffin embedded tissues, blood, DNA, RNA, and protein samples from mesothelioma patients. Demographic data includes age, sex, race, and occupational history. Clinical data includes stage, treatment, and survival information.
The virtual registry and tissue bank also serve as a virtual repository and offer a library of biospecimens and data that investigators can use and share, including genomic, transcriptomic, and proteomic data.
The NMVB can:
- Help identify early signs of disease.
- Support the development of biomarkers that show disease stage and prognosis.
- Help develop new or improved treatment options.
The goal is to continue to expand the NMVB and improve its ability to be a resource for both biomedical researchers and the clinical science community focused on malignant mesothelioma research.
Eligibility
Applicant institution must have an established registry and tissue bank with the capability of functioning as a national virtual registry and tissue bank for mesothelioma, one in which participating institutions will make available their independent stores of mesothelioma tissue for public access and use through a centralized Internet-based database or registry. This virtual registry and tissue bank must be able to provide a resource for investigators engaged in the research of mesothelioma, to include, but not limited to, biospecimens (blood, plasma, white blood cells, and normal and malignant mesothelioma tissues) together with demographic data such as age, sex, race, occupational history and other epidemiologic information, and clinical data (stage, treatment and survival information).Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are not allowed.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity